SCHEMBL929207

SCHEMBL929207

C1=C2NCCCN2CCCC1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
HRH1 P35367 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11301415 0.98 CHKA (0.30) CHKACHRNB2CHRNA4
SCHEMBL1782998 0.93 CHRNB2 (0.32) CHRNB2CHRNA4
SCHEMBL466550 0.91 KDM4E (0.32) CHKAHRH1
SCHEMBL7877977 0.89
SCHEMBL20550342 0.84
SCHEMBL2819147 0.75
SCHEMBL15364407 0.71 CHRNB2 (0.33) CHRNB2CHRNA4
SCHEMBL6406381 0.70 CHRNB2 (0.33) CHRNB2CHRNA4HRH1
SCHEMBL8374849 0.65 MAPT (0.38)
SCHEMBL9904083 0.64 APAF1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289851-A1 CYCLIC PEPTIDES FOR DELIVERING THERAPEUTICS ENTRADA THERAPEUTICS, INC. 2025-09-18 US disclosed
EP-4539986-A2 CATALYTIC SYSTEM CONTAINING IONIC LIQUIDS AND A PROCESS FOR PRODUCING HYDROGEN FROM PLASTIC MATERIALS USING SAID CATALYTIC SYSTEM Fundación Centro de Investigación Cooperativa de Energías Alternativas, CIC Energigune Fundazioa (ES) 2025-04-23 EP disclosed
US-20240199553-A1 DIFLUOROMETHYLATION REACTION OF HETEROCYCLIC RING USING TETRAFLUOROETHYLENE AGC Inc. (JP) 2024-06-20 US disclosed
US-20240139371-A1 NEW ANTIMICROBIAL AND ANTITHROMBOGENIC MEDICAL DEVICE UNIV LIEGE (BE) 2024-05-02 US disclosed
CN-117897377-A Difluoromethylation of heterocycles using tetrafluoroethylene AGC株式会社 2024-04-16 CN disclosed
EP-4298151-A1 NEW ANTIMICROBIAL AND ANTITHROMBOGENIC MEDICAL DEVICE Université de Liège (BE) 2024-01-03 EP disclosed
WO-2023242335-A2 CATALYTIC SYSTEM CONTAINING IONIC LIQUIDS AND A PROCESS FOR PRODUCING HYDROGEN FROM PLASTIC MATERIALS USING SAID CATALYTIC SYSTEM FUNDACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA DE ENERGÍAS ALTERNATIVAS CIC ENERGIGUNE FUNDAZIOA (ES) 2023-12-21 WO disclosed
WO-2023162868-A1 COMPOSITION 富士フイルム株式会社 2023-08-31 WO disclosed
US-11685761-B2 Cyclic di-nucleotide compounds as sting agonists MERCK SHARP & DOHME LLC (US) 2023-06-27 US disclosed
EP-4110776-A1 NEW MACROCYCLIC COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Les Laboratoires Servier (FR) 2023-01-04 EP disclosed
US-6077866-A EXHIBIT POWERFUL INSECTICIDAL ACTION, ESPECIALLY AGAINST LEPIDOPTERA, COLEOPTERA AND SOIL INSECTS NIHON BAYER AGROCHEM K.K. (JP) 2000-06-20 US disclosed
EP-0742202-B1 Benzophenone hydrazone derivatives as insecticides BAYER AGROCHEM KK (JP) 1999-12-01 EP disclosed
US-5869508-A MICROBIOCIDES NIHON BAYER AGROCHEM K.K. (JP) 1999-02-09 US disclosed
EP-0662476-B1 Process for the preparation of bicyclic amidines LONZA AG (CH) 1999-01-20 EP disclosed
US-5849767-A Chloropyridylcarbonyl derivatives NIHON BAYER AGROCHEM K.K. (JP) 1998-12-15 US disclosed
EP-0816363-A1 1,2,3-Benzothiadiazole derivatives and their use as microbicides NIHON BAYER AGROCHEM K.K. (JP) 1998-01-07 EP disclosed
EP-0763530-A1 Chloropyridylcarbonyl derivatives and their use as microbiocides NIHON BAYER AGROCHEM K.K. (JP) 1997-03-19 EP disclosed
EP-0742202-A2 Benzophenone hydrazone derivatives as insecticides NIHON BAYER AGROCHEM K.K. (JP) 1996-11-13 EP disclosed
US-5308608-A Compounds for destroying viruses, cells and tissues UNIVERSITY OF BRITISH COLUMBIA (CA) 1994-05-03 US disclosed
US-5149708-A Useful for detection and treatment of malignant cells, combined with irradiation UNIVERSITY OF BRITISH COLUMBIA (CA) 1992-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199553-A1 DIFLUOROMETHYLATION REACTION OF HETEROCYCLIC RING USING TETRAFLUOROETHYLENE CYP2F1, CYP2E1, AFF1 CHKA 1204/4885CHRNB2 3218/4885CHRNA4 3327/4885
US-20250289851-A1 CYCLIC PEPTIDES FOR DELIVERING THERAPEUTICS IAPP, LNPEP, CFTR CHKA 2051/4885CHRNB2 4086/4885CHRNA4 4714/4885
US-11685761-B2 Cyclic di-nucleotide compounds as sting agonists STING1, CGAS, IFNAR1 CHKA 4183/4885CHRNB2 1506/4885CHRNA4 1815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.